PIMECROLIMUS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pimecrolimus, and when can generic versions of Pimecrolimus launch?
Pimecrolimus is a drug marketed by Actavis Labs Ut Inc and Glenmark Pharms Ltd and is included in two NDAs.
The generic ingredient in PIMECROLIMUS is pimecrolimus. There are five drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the pimecrolimus profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pimecrolimus
A generic version of PIMECROLIMUS was approved as pimecrolimus by ACTAVIS LABS UT INC on December 27th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PIMECROLIMUS?
- What are the global sales for PIMECROLIMUS?
- What is Average Wholesale Price for PIMECROLIMUS?
Summary for PIMECROLIMUS
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Clinical Trials: | 59 |
| Patent Applications: | 4,005 |
| Drug Prices: | Drug price information for PIMECROLIMUS |
| What excipients (inactive ingredients) are in PIMECROLIMUS? | PIMECROLIMUS excipients list |
| DailyMed Link: | PIMECROLIMUS at DailyMed |
Recent Clinical Trials for PIMECROLIMUS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Hepatology & Tropical Medicine Research Institute | Phase 4 |
| Combined Military Hospital Abbottabad | Phase 1 |
| Postgraduate Institute of Dental Sciences Rohtak | Phase 4 |
Pharmacology for PIMECROLIMUS
| Drug Class | Calcineurin Inhibitor Immunosuppressant |
| Mechanism of Action | Calcineurin Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for PIMECROLIMUS
US Patents and Regulatory Information for PIMECROLIMUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Ut Inc | PIMECROLIMUS | pimecrolimus | CREAM;TOPICAL | 209345-001 | Dec 27, 2018 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Glenmark Pharms Ltd | PIMECROLIMUS | pimecrolimus | CREAM;TOPICAL | 211769-001 | Aug 29, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
